List To Watch: Six Flags Entertainment Corporation (NYSE:SIX), IAMGOLD Corp. (NYSE:IAG), Sanofi SA (NYSE:SNY), Adaptimmune Therapeutics plc (NASDAQ:ADAP)

Aircastle LTD (NYSE:AYR) shares fell -1.07% in last trading session and ended the day at $19.34. AYR has a return on assets of 2.50%. Aircastle LTD (NYSE:AYR) quarterly performance is -5.51%.

On 18 February, Aircastle Limited (NYSE:AYR) announced that it formed an aircraft leasing joint venture with IBJ Leasing Co., Ltd. (“IBJL’”), a Japanese general leasing company which is part of Mizuho Financial Group. The joint venture, which will be serviced by Aircastle, will target investments in newer narrow-body aircraft leased to premier airlines. It is expected the joint venture will purchase its first two aircraft from Aircastle and that future aircraft investments will be acquired directly. Aircastle will own 25% of the joint venture.

Six Flags Entertainment Corporation (NYSE:SIX) ended the last trading day at $51.50. Company weekly volatility is calculated as 3.23% and price to cash ratio as 47.26. Six Flags Entertainment Corporation (NYSE:SIX) showed a weekly performance of 0.21%.

On 18 February, Six Flags Entertainment Corporation (NYSE:SIX), the world’s largest regional theme park company, announced that 2015 represented its sixth consecutive year of record financial performance as it grew revenue $88 million or 7 percent to $1.3 billion and grew Adjusted EBITDA2 $42 million or 10 percent to $481 million. The full-year revenue and EBITDA growth resulted primarily from an 11 percent increase in the number of guests visiting Six Flags parks, along with modestly higher ticket prices, success of the company’s all season dining program, and an increase in international licensing fees.

On 24 February, IAMGOLD Corp. (NYSE:IAG) shares moved up 0.42% and was closed at $2.38. IAG EPS growth in last 5 year was -40.70%. IAMGOLD Corp. (NYSE:IAG) year to date (YTD) performance is 67.61%.

On 17 February, IAMGOLD Corporation (NYSE:IAG) reports its consolidated financial and operating results for the quarter and year ended December 31, 2015. Attributable gold production of 806,000 oz exceeded mid-point of guidance range. All-in sustaining costs1 of $1,118/oz were within guidance and would have been $61 per ounce lower excluding the impact of realized hedge and non-hedge derivative losses ($63/oz) and the purchase of assets held under finance leases at Rosebel ($33/oz), partially offset by normalization of Westwood’s costs following the interruption in production ($35/oz).

Sanofi SA (ADR) (NYSE:SNY) shares moved up 1.11% in last trading session and ended the day at $39.04. SNY Gross Margin is 68.70% and its has a return on assets of 9.50%. Sanofi SA (ADR) (NYSE:SNY) quarterly performance is -11.65%.

Sanofi (NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for its investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 diabetes.

Adaptimmune Therapeutics plc (NASDAQ:ADAP) caters to the Healthcare space. Its weekly performance is -13.48%. On the last day of trading company shares ended up at $7.38.

Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, announced that James Noble, Chief Executive Officer of Adaptimmune, presented at the 2016 RBC Capital Markets Global Healthcare Conference on Wednesday, February 24 at 11:00 AM ET (4:00 PM GMT).